NKTR NEKTAR THERAPEUTICS: institutional ownership and insider trading
251 funds reported holding $2.70B of NEKTAR THERAPEUTICS in their latest 13F filings; in Q2 2026 funds net bought $679M, with 72 new positions and 41 funds selling out; over the last 12 months insiders bought $0 and sold $2.43M on the open market; over its last four quarters it reported revenue of $54.6M and net income of −$157M.
NKTR revenue and earnings
- Quarter ended Jun 30, 2026: revenue $10.1M, net income −$40.6M, EPS -1.23
- Quarter ended Mar 31, 2026: revenue $10.9M, net income −$44.9M, EPS -1.82
- Quarter ended Dec 31, 2025: revenue $21.8M, net income −$36.0M, EPS -1.29
- Quarter ended Sep 30, 2025: revenue $11.8M, net income −$35.5M, EPS -1.87
Famous investors holding NKTR
- Two Sigma (Two Sigma Investments): $83.9M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $45.2M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $34.8M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $775K, 0.0% of the portfolio
Largest institutional holders of NKTR
- FMR LLC — $354M
- BlackRock, Inc. (BLK) — $205M
- Two Seas Capital LP — $203M
- BVF INC/IL — $167M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $105M
- VANGUARD CAPITAL MANAGEMENT LLC — $104M
- TWO SIGMA INVESTMENTS, LP — $83.9M
- Vestal Point Capital, LP — $69.8M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $65.4M
- STATE STREET CORP (STT, STT-PG) — $63.5M
Recent NKTR insider trades
- Aug 18, 2026: Robin Howard W sold 418 shares ($30.1K)
- Aug 18, 2026: Zalevsky Jonathan sold 186 shares ($13.4K)
- Jun 30, 2026: Zalevsky Jonathan sold 5,681 shares ($398K)
- Jun 17, 2026: Robin Howard W sold 20,000 shares ($1.22M)
5%+ owners
- FMR LLC: 15.0% (Schedule 13G/A, filed May 6, 2026)
- Two Seas Capital LP: 9.8% (Schedule 13G/A, filed Sep 28, 2026)
- BlackRock, Inc.: 7.8% (Schedule 13G, filed Jul 29, 2026)
- BVF PARTNERS L P/IL: 7.1% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Jul 31, 2026)
Who owns the most NKTR stock?
The largest institutional holders of NEKTAR THERAPEUTICS in the latest 13F filings are FMR LLC ($354M), BlackRock, Inc. (BLK) ($205M), Two Seas Capital LP ($203M).
Are insiders buying or selling NKTR?
Over the last 12 months insiders bought $0 and sold $2.43M of NEKTAR THERAPEUTICS stock on the open market (SEC Form 4).
Which famous investors own NKTR?
Two Sigma, Izzy Englander, Ken Griffin, D. E. Shaw.
What was NKTR's revenue last quarter?
NEKTAR THERAPEUTICS reported revenue of $10.1M for the quarter ended June 30, 2026, with net income of −$40.6M.
Which ETFs hold NKTR?
19 ETFs and mutual funds hold it among their top 100 positions, including FDGRX, FGKFX, FCGSX, XPH.